Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mucositis × Cytarabine × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Leukemia, Myeloid, Acute 241 Leukemia 175 Precursor Cell Lymphoblastic Leukemia-Lymphoma 112 Lymphoma 96 Congenital Abnormalities 59 Myelodysplastic Syndromes 55 Leukemia, Myelomonocytic, Acute 53 Leukemia, Monocytic, Acute 53 Leukemia, Erythroblastic, Acute 51 Leukemia, Megakaryoblastic, Acute 49 Lymphoma, Non-Hodgkin 45 Lymphoma, Mantle-Cell 38 Burkitt Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 36 Lymphoma, Follicular 29 Leukemia, Myelomonocytic, Chronic 27 Hodgkin Disease 24 Anemia, Refractory, with Excess of Blasts 24 Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Large-Cell, Immunoblastic 22 Blast Crisis 21 Recurrence 18 Myeloproliferative Disorders 18 Leukemia, Eosinophilic, Acute 17 Leukemia, Basophilic, Acute 15 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Promyelocytic, Acute 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Leukemia, Myeloid, Chronic-Phase 13 Leukemia, Biphenotypic, Acute 13

Interventions

Radiotherapy 5 Injections 3 Fibroblast Growth Factor 7 3 Drug Therapy 3 Xylitol 2 Water 2 Propolis 2 Mouthwashes 2 Morphine 2 Methotrexate 2 Melphalan 2 Interleukin 1 Receptor Antagonist Protein 2 Gabapentin 2 Cisplatin 2 peppermint oil 1 pegaspargase 1 oxycodone-acetaminophen 1 nelarabine 1 kang-lai-te 1 glucarpidase 1 fludarabine phosphate 1 fish oil triglycerides 1 cyclohexaneacetic acid 1 calcium phosphate 1 brilacidin 1 anise oil 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 acetaminophen, hydrocodone drug combination 1 Whole-Body Irradiation 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡